Vertex Pharmaceuticals Stock Market Value
| VRTX Stock | USD 468.29 0.93 0.20% |
| Symbol | Vertex |
Vertex Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.01 | Earnings Share (1.88) | Revenue Per Share 41.185 | Quarterly Revenue Growth 0.116 | Return On Assets 0.1205 |
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vertex Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vertex Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vertex Pharmaceuticals.
| 12/23/2022 |
| 12/12/2024 |
If you would invest 0.00 in Vertex Pharmaceuticals on December 23, 2022 and sell it all today you would earn a total of 0.00 from holding Vertex Pharmaceuticals or generate 0.0% return on investment in Vertex Pharmaceuticals over 720 days. Vertex Pharmaceuticals is related to or competes with Biomarin Pharmaceutical, Sarepta Therapeutics, Alnylam Pharmaceuticals, Intellia Therapeutics, Editas Medicine, Beam Therapeutics, and Ginkgo Bioworks. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for tr... More
Vertex Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vertex Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vertex Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.8 | |||
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 9.8 | |||
| Value At Risk | (2.91) | |||
| Potential Upside | 2.38 |
Vertex Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vertex Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vertex Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Vertex Pharmaceuticals historical prices to predict the future Vertex Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0083 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.27) | |||
| Sortino Ratio | (0.07) | |||
| Treynor Ratio | (0.01) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vertex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vertex Pharmaceuticals Backtested Returns
Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0248, which indicates the firm had a -0.0248% return per unit of risk over the last 3 months. Vertex Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vertex Pharmaceuticals' Coefficient Of Variation of 28128.03, semi deviation of 1.77, and Risk Adjusted Performance of 0.0083 to confirm the risk estimate we provide. The entity has a beta of 0.67, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vertex Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Vertex Pharmaceuticals is expected to be smaller as well. At this point, Vertex Pharmaceuticals has a negative expected return of -0.0424%. Please make sure to validate Vertex Pharmaceuticals' value at risk, kurtosis, price action indicator, as well as the relationship between the semi variance and rate of daily change , to decide if Vertex Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.67 |
Good predictability
Vertex Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Vertex Pharmaceuticals time series from 23rd of December 2022 to 18th of December 2023 and 18th of December 2023 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vertex Pharmaceuticals price movement. The serial correlation of 0.67 indicates that around 67.0% of current Vertex Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 1042.49 |
Vertex Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Vertex Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vertex Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Vertex Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Vertex Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vertex Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vertex Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vertex Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vertex Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Vertex Pharmaceuticals Lagged Returns
When evaluating Vertex Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vertex Pharmaceuticals stock have on its future price. Vertex Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vertex Pharmaceuticals autocorrelation shows the relationship between Vertex Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Vertex Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.